Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab

by Shiho Iwagaitsu, Taio Naniwa
Published 2017-01-01

The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis

by Shinji Maeda, Yoshihito Hayami, Taio Naniwa, Ryuzo Ueda
Published 2012-01-01

Successful Use of Higher-Dose Etanercept for Multirefractory Systemic Flare of Adult-Onset Still’s Disease with Liver Failure with No Response to Tocilizumab Therapy

by Taio Naniwa, Shinya Tamechika, Shiho Iwagaitsu, Shinji Maeda, Hiroyuki Togawa
Published 2013-01-01

Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis...

by Shin-ya Tamechika, Shuntaro Isogai, Shinji Maeda, Taio Naniwa, Akio Niimi
Published 2021-01-01

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research.

by Shinji Maeda, Satoshi Osaga, Tomoyo Maeda, Norihisa Takeda, Shin-Ya Tamechika, Taio Naniwa, Akio Niimi
Published 2019-01-01

Drug-induced Hypersensitivity Syndrome Associated with a Marked Increase in Anti-paramyxovirus Antibody Titers in a Scleroderma Patient

by Taio Naniwa, Shinji Maeda, Hiroo Sawada, Yuko Watanabe, Tomoyo Osawa, Yoshihito Hayami, Shogo Banno, Akimichi Morita, Ryuzo Ueda
Published 2007-01-01

Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions

by Takahiko Sugihara, Hitoshi Hasegawa, Haruhito A. Uchida, Hajime Yoshifuji, Yoshiko Watanabe, Eisuke Amiya, Yasuhiro Maejima, Masanori Konishi, Yohko Murakawa, Noriyoshi Ogawa, Shunsuke Furuta, Yasuhiro Katsumata, Yoshinori Komagata, Taio Naniwa, Takahiro Okazaki, Yoshiya Tanaka, Tsutomu Takeuchi, Yoshikazu Nakaoka, Yoshihiro Arimura, Masayoshi Harigai, Mitsuaki Isobe, Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis (JPVAS)
Published 2020-04-01